| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
BioRestorative Therapies, Inc.
13G/A
Amendment 7
BRTX · 090655606
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
| Auctus Fund, LLC | 9.9% | ||||
| Auctus Fund Management LLC | 9.9% | ||||
| Alfred Sollami | 9.9% | ||||
| Louis Posner | 9.9% | ||||
|
BioRestorative Therapies, Inc.
13G/A
Amendment 6
BRTX · 090655606
|
9.9% |
2/17/2026
Event 12/31/2025
|
|||
| Auctus Fund, LLC | 9.9% | ||||
| Auctus Fund Management LLC | 9.9% | ||||
| Alfred Sollami | 9.9% | ||||
| Louis Posner | 9.9% | ||||
|
BioRestorative Therapies, Inc.
13G/A
Amendment 5
BRTX · 090655606
|
9.9% |
8/14/2025
Event 6/30/2025
|
|||
| Auctus Fund, LLC | 9.9% | ||||
| Auctus Fund Management LLC | 9.9% | ||||
| Alfred Sollami | 9.9% | ||||
| Louis Posner | 9.9% | ||||
|
BioRestorative Therapies, Inc.
13G/A
Amendment 4
BRTX · 090655606
|
9.9% |
5/15/2025
Event 3/31/2025
|
|||
| Auctus Fund Management LLC | 9.9% | ||||
| Auctus Fund, LLC | 9.9% | ||||
| Alfred Sollami | 9.9% | ||||
| Louis Posner | 9.9% | ||||
|
Guided Therapeutics Inc
13G/A
Amendment 3
GTHP · 40171F501
|
9.9% |
11/14/2024
Event 9/30/2024
|
|||
| Auctus Fund Management LLC | 9.9% | ||||
| Auctus Fund, LLC | 9.9% | ||||
| Alfred Sollami | 9.9% | ||||
| Louis Posner | 9.9% | ||||
|
BioRestorative Therapies, Inc.
13G/A
Amendment 3
BRTX · 090655606
|
9.9% |
11/14/2024
Event 9/30/2024
|
|||
| Auctus Fund Management LLC | 9.9% | ||||
| Auctus Fund, LLC | 9.9% | ||||
| Alfred Sollami | 9.9% | ||||
| Louis Posner | 9.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.